SPARC - Weekly AnalysisIn the Weekly Chart of SPARC ,
we can see that; it is at decision making point.
Possible momentums are shown in chart.
−12.60 INR
−3.87 B INR
755.45 M INR
81.61 M
About SUN PHARMA ADV.RES.CO.LTD
Sector
CEO
Anilkumar Raghavan
Headquarters
Mumbai
Website
Founded
2006
ISIN
INE232I01014
FIGI
BBG000R3LSK6
Sun Pharma Advanced Research Co. Ltd. is a bio-pharmaceutical company, which engages in the research and development of pharmaceuticals. It operates through the Within India and Outside India geographical segments. The company was founded on March 1, 2006, and is headquartered in Mumbai, India.
SPARC Breaking Channel Formation Above 250Details:
Asset: Sun Pharma Advanced Research Company Ltd (SPARC)
Breakout Level: Above 250
Potential Target: Upside momentum expected
Stop Loss: Below breakout level or as per risk tolerance
Timeframe: Short to medium-term
Rationale: Sun Pharma Advanced Research Company Ltd (SPARC) is showing signs
SPARC(Sun Pharma Advance Research) is ready to sparkleThis is a SUNPHARMA group of company a renowned name in Pharma industry and one of the biggest pharma company.
SPARC is at very good technical levels (Demand Area on monthly time frame).
It consolidated for more than 30 days, it formed a rectangle pattern.
it is ready for a rectangle breakout.
It
SPARC - BO FAIL, IMPORTANT RISK MANAGEMENT LESSONHello Community,
today i will talk about the importance of risk management in stock market, why its important to respect risk in stock market with proper stoploss method you should have as per your risk apetite with example. We have talked much about the BO stocks which had made good money for us b
SPARC Breakout from down channel SPARC Breakout from down channel
SPARC trending downwards from recent highs in channel.
In last couple of days it has broken out of the channel and primed for all time high
SPARC ON FIRE The stock has been foriming a cup and handle pattern and has given a breakout from the same moreover the volumes in the stock are quite reliable 528 and 718 levels can be achieved soon
SPARC-A spark of a bull run visible!SPARC is a loss making company, hence this is purely a technical pick.
Stock has given beautiful trendline breakout and is in consolidation since breakout.
Above 400, stock can fly to ATH.
Risky traders can enter at CMP for better risk reward.
sparcstock : sparc
trade : long (cash segment)
buy @ 436
sl @ 408
target 1 @ 530
target 2 @ 590
note :
this information is for education only
Breakout confirmed in SPARCRound Bottom Breakout
RSI above 70 and rising
Trading above EMA50
Volume increasing
Disc: for. Study, not a recommendation
SPARC - Ichimoku Breakout📈 Stock Name - Sun Pharma Advanced Research Company Limited
🌐 Ichimoku Cloud Setup:
1️⃣ Today's close is above the Conversion Line.
2️⃣ Future Kumo is Turning Bullish.
3️⃣ Chikou span is slanting upwards.
All these parameters are shouting BULLISH at the Current Market Price and even more bullis
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SPARC is 203.30 INR — it has increased by 7.35% in the past 24 hours. Watch SUN PHARMA ADVANCED RESEARCH C stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange SUN PHARMA ADVANCED RESEARCH C stocks are traded under the ticker SPARC.
SPARC stock has risen by 2.23% compared to the previous week, the month change is a −2.57% fall, over the last year SUN PHARMA ADVANCED RESEARCH C has showed a −21.35% decrease.
SPARC reached its all-time high on Mar 10, 2015 with the price of 598.00 INR, and its all-time low was 81.00 INR and was reached on Mar 25, 2020. View more price dynamics on SPARC chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SPARC stock is 2.41% volatile and has beta coefficient of 1.03. Track SUN PHARMA ADVANCED RESEARCH C stock price on the chart and check out the list of the most volatile stocks — is SUN PHARMA ADVANCED RESEARCH C there?
Today SUN PHARMA ADVANCED RESEARCH C has the market capitalization of 66.33 B, it has decreased by −2.06% over the last week.
Yes, you can track SUN PHARMA ADVANCED RESEARCH C financials in yearly and quarterly reports right on TradingView.
SPARC net income for the last quarter is −1.07 B INR, while the quarter before that showed −959.00 M INR of net income which accounts for −11.92% change. Track more SUN PHARMA ADVANCED RESEARCH C financial stats to get the full picture.
No, SPARC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 25, 2024, the company has 603.00 employees. See our rating of the largest employees — is SUN PHARMA ADVANCED RESEARCH C on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SUN PHARMA ADVANCED RESEARCH C EBITDA is −4.05 B INR, and current EBITDA margin is −528.15%. See more stats in SUN PHARMA ADVANCED RESEARCH C financial statements.
Like other stocks, SPARC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SUN PHARMA ADVANCED RESEARCH C stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SUN PHARMA ADVANCED RESEARCH C technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SUN PHARMA ADVANCED RESEARCH C stock shows the sell signal. See more of SUN PHARMA ADVANCED RESEARCH C technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.